8-K filed February 13, 2024, 6:59 PM ET ticker PALI CIK 0001357459

leadership confidence high sentiment neutral materiality 0.60

Palisade Bio reduces board from 8 to 4; four directors resign, Chairman changed

PALISADE BIO, INC.

Directors James Neal, Stephanie Diaz, Cristina Csimma, Robert Trenschel resigned immediately; no disagreement cited.
Board cut from 8 to 4 members; Donald Williams appointed Chairman.
Recent warrant exercise generated $2.5 million gross proceeds.
PALI-2108 Phase 1 study on track to start before end of 2024; IND/CTA submission planned by year end.
Positive preclinical data presented at 2024 Crohn's & Colitis Congress; second milestone payment received from IBD Ventures.

item 5.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Robert Trenschel

Director

PALI · PALISADE BIO, INC.

Effective: 2024-02-13
Filed: February 13, 2024, 6:59 PM ET

James Neal, Stephanie Diaz, Dr. Cristina Csimma, and Dr. Robert Trenschel (collectively, the “Resigning Directors”), informed the board of directors (“Board”) of Palisade Bio, Inc. (the “Company”) that each is resigning as a member of the Board effective immediately.

Departed

James Neal

Director

PALI · PALISADE BIO, INC.

Effective: 2024-02-13
Filed: February 13, 2024, 6:59 PM ET

James Neal, Stephanie Diaz, Dr. Cristina Csimma, and Dr. Robert Trenschel (collectively, the “Resigning Directors”), informed the board of directors (“Board”) of Palisade Bio, Inc. (the “Company”) that each is resigning as a member of the Board effective immediately.

Departed

Stephanie Diaz

Director

PALI · PALISADE BIO, INC.

Effective: 2024-02-13
Filed: February 13, 2024, 6:59 PM ET

James Neal, Stephanie Diaz, Dr. Cristina Csimma, and Dr. Robert Trenschel (collectively, the “Resigning Directors”), informed the board of directors (“Board”) of Palisade Bio, Inc. (the “Company”) that each is resigning as a member of the Board effective immediately.

Departed

Cristina Csimma

Director

PALI · PALISADE BIO, INC.

Effective: 2024-02-13
Filed: February 13, 2024, 6:59 PM ET

James Neal, Stephanie Diaz, Dr. Cristina Csimma, and Dr. Robert Trenschel (collectively, the “Resigning Directors”), informed the board of directors (“Board”) of Palisade Bio, Inc. (the “Company”) that each is resigning as a member of the Board effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Robert Trenschel resigned as Director at PALISADE BIO, INC..

Action: resigned
Role: Director

Exact text from the filing

James Neal, Stephanie Diaz, Dr. Cristina Csimma, and Dr. Robert Trenschel (collectively, the “Resigning Directors”), informed the board of directors (“Board”) of Palisade Bio, Inc. (the “Company”) that each is resigning as a member of the Board effective immediately.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

James Neal resigned as Director at PALISADE BIO, INC..

Action: resigned
Role: Director

Exact text from the filing

James Neal, Stephanie Diaz, Dr. Cristina Csimma, and Dr. Robert Trenschel (collectively, the “Resigning Directors”), informed the board of directors (“Board”) of Palisade Bio, Inc. (the “Company”) that each is resigning as a member of the Board effective immediately.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Stephanie Diaz resigned as Director at PALISADE BIO, INC..

Action: resigned
Role: Director

Exact text from the filing

James Neal, Stephanie Diaz, Dr. Cristina Csimma, and Dr. Robert Trenschel (collectively, the “Resigning Directors”), informed the board of directors (“Board”) of Palisade Bio, Inc. (the “Company”) that each is resigning as a member of the Board effective immediately.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Cristina Csimma resigned as Director at PALISADE BIO, INC..

Action: resigned
Role: Director

Exact text from the filing

James Neal, Stephanie Diaz, Dr. Cristina Csimma, and Dr. Robert Trenschel (collectively, the “Resigning Directors”), informed the board of directors (“Board”) of Palisade Bio, Inc. (the “Company”) that each is resigning as a member of the Board effective immediately.

View on SEC.gov

PALISADE BIO, INC. filing history →

Source: SEC EDGAR

accession 0001493152-24-006132

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.